(Q28287484)

1

0 references

I Bernard

2

0 references

F Maillet

3

0 references

J C Mani

4

0 references

M Fontaine

5

0 references

J Y Bonnefoy

6

0 references

M D Kazatchkine

7

0 references

E Fischer

European Journal of Immunology

8

0 references

language of work or name

English

0 references

publication date

July 1996

0 references

published in

0 references

volume

26

0 references

issue

7

0 references

page(s)

1497-503

0 references

cites work

Properties of Soluble CR2 in Human Serum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

CD21 is a ligand for CD23 and regulates IgE production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Determination of soluble CD21 as a parameter of B cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Physiological enzymatic cleavage of leukocyte membrane molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021

CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260714

7 January 2021